Phaarmasia Peer Comparison

BSE: 523620

₹89.55

₹0.00 (0.00%)

As on 28-Sep-2026IST

Market cap

₹61 Cr

Revenue (TTM)

₹49 Cr

P/E Ratio

3.5

P/B Ratio

2.7

Div. Yield

0 %

Edit

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Market cap (₹ Cr)	61	21,684	20,012	18,151	17,148
Revenue (₹ Cr)	49	2,287	1,682	2,570	3,230
Net Profit (₹ Cr)	17.65	678.07	273.51	735.15	666.92
Net Margin (%)	35.60	28.10	16.19	26.88	20.60
RoE (%)	12.94	19.73	11.15	19.16	18.75
Price to Earnings	3.46	32.59	67.31	24.69	26.63
Price-To-Book	2.72	5.90	7.45	4.12	4.25

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Operating Revenue	48.62	2,287.33	1,682.47	2,569.77	3,229.67
Total Income	49.57	2,413.29	1,689.83	2,735.39	3,237.12
Total Expenditure	46.78	1,490.75	1,203.91	1,628.14	2,090.06
EBITDA	1.83	796.58	478.55	941.63	1,139.61
Depreciation	0.19	78.10	126.01	57.58	281.06
EBIT	1.64	718.48	352.55	884.05	858.55
Interest	0.21	0.88	52.11	7.69	190.64
Other Income	0.95	125.96	7.37	165.62	7.45
Exceptional Items	19.00	0.00	12.16	-49.16	-17.24
Profit before Tax	21.38	843.56	319.96	992.82	658.12
Provision for Tax	3.74	165.49	46.45	257.67	-8.80
Profit after Tax	17.65	678.07	273.51	735.15	666.92

Liabilities (₹ Cr)

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Shareholder's Funds	22.10	3,586.42	2,591.20	4,202.90	3,902.67
Minority Interest	0.00	-12.71	0.00	0.00	-21.81
Non-Current Liabilities	1.37	28.74	266.35	91.50	1,392.75
Current Liabilities	6.60	385.94	848.06	627.48	2,077.10
Total Liabilities	21.68	3,207.85	3,310.68	4,911.11	6,865.52

Assets (₹ Cr)

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Non-Current Assets	1.06	1,291.22	2,525.44	770.28	5,617.77
Current Assets	26.74	2,585.66	1,109.77	3,803.22	1,539.85
Total Assets	21.68	3,207.85	3,310.68	4,911.11	6,865.52
Total Debt*	0.00	0.55	586.37	2.50	2,421.66
Net Current Assets	20.14	2,199.72	261.71	3,175.74	-537.25
Contingent Liabilities	0.16	0.64	76.22	363.79	51.96

Cashflow (₹ Cr)

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Cash From Operating Activities	0.00	432.37	132.27	659.75	1,065.01
Cash Flow from Investing Activities	-0.12	-334.73	-199.13	-71.34	-79.97
Cash from Financing Activities	-0.15	-38.32	62.65	-205.34	-881.32
Net Cash Inflow / Outflow	-0.27	59.32	-4.21	383.07	103.72

Ratios

Profitability Ratios

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
ROCE (%)	-30.07	26.22	6.95	26.21	13.59
ROE (%)	12.94	19.73	11.15	19.16	18.75
ROA (%)	68.36	18.69	7.80	14.95	9.26
EBIT Margin (%)	3.38	31.41	20.95	34.40	26.58
Net Margin (%)	35.60	28.10	16.19	26.88	20.60
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Revenue Growth (%)	111.83	15.01	27.91	10.69	9.59
EBIT Growth (%)	168.06	18.45	58.32	24.14	16.84
Net Profit Growth (%)	1,204.88	19.61	149.56	-9.09	62.68
EPS Growth (%)	233.03	17.73	-3.57	14.40	67.41
Book Value Growth (%)	-25.79	23.77	30.63	17.30	10.19

Valuation Ratios

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Price / Earnings	28.78	32.59	71.40	23.53	25.96
Price / Book Value	2.72	5.90	7.45	4.12	4.25
Dividend Yield (%)	0.00	0.28	0.06	1.89	0.00
EV/EBITDA	33.15	25.96	43.10	15.98	17.02
Market Cap (₹ Cr)	20.01	15,219.80	6,484.12	18,318.10	19,292.77

Solvency Ratios

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debt to Equity	0.05	0.00	0.07	0.00	0.24
Short term debt to equity ratio	--	0.00	0.13	0.00	0.14
Current Ratio	4.05	6.70	1.31	6.06	0.74
Quick Ratio	3.39	5.59	0.88	5.31	0.53
Interest Coverage	105.30	959.59	7.14	130.11	4.45

Operating Efficiency Ratios

	Phaarmasia	Caplin Point Lab	Shilpa Medicare	Pfizer	Eris Lifesciences
Debtors to sales (%)	10.56	36.10	30.84	7.07	21.07
Asset Turnover	1.88	0.63	0.48	0.52	0.45
Receivable days	83.55	110.70	118.15	29.10	54.06
Inventory Days	86.55	65.86	98.29	69.53	32.16
Payable days	406.82	105.88	128.16	76.77	140.91
Cash Conversion Cycle	-236.72	70.68	88.28	21.86	-54.69

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly